Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Benitec Biopharma Limited (BNTC) had Debt to Capital Ratio of 0.00 for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-12.81M |
|
-- |
|
-- |
|
$14.43M |
|
$-14.43M |
|
$1.62M |
|
$-12.81M |
|
$-12.81M |
|
$-12.81M |
|
$-12.81M |
|
$-12.81M |
|
$-12.81M |
|
$-14.43M |
|
$-14.41M |
|
46.56M |
|
46.56M |
|
$-0.26 |
|
$-0.26 |
|
| Balance Sheet Financials | |
$181.69M |
|
$0.18M |
|
$0.94M |
|
$182.62M |
|
$5.34M |
|
$0.27M |
|
$0.27M |
|
$5.61M |
|
$177.01M |
|
$177.01M |
|
$177.01M |
|
34.42M |
|
| Cash Flow Statement Financials | |
$-16.52M |
|
$-0.10M |
|
$98.98M |
|
$97.86M |
|
$180.09M |
|
$82.23M |
|
$26.41M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
34.00 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.00 |
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-16.62M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-7.24% |
|
-7.24% |
|
-7.01% |
|
-7.23% |
|
$5.14 |
|
$-0.36 |
|
$-0.35 |
|